ONESOURCE
Invest with MTF
Invest Now
Invest in OneSource Specialty Pharma with 2.71X leverage
OneSource Specialty Pharma live price: ₹1335.2. It opened at ₹1,283 vs previous close ₹1,310; intraday high/low: ₹1,343/₹1,258. The 50 & 200 DMA stand at ₹1,410.02/₹1,614.84.
OneSource Specialty Pharma Performance
- Low
- ₹1,258
- High
- ₹1,343
- 52 Week Low
- ₹1,057
- 52 Week High
- ₹2,248
- Open Price₹1,283
- Previous Close₹1,310
- Volume194,487
- 50 DMA₹1,410.02
- 100 DMA₹1,534.03
- 200 DMA₹1,614.84
Investment Returns
- Over 1 Month + 13.38%
- Over 3 Month -19%
- Over 6 Month -29.69%
- Over 1 Year + 0.64%
Smart Investing Starts Here Start SIP with OneSource Specialty Pharma for Steady Growth!
OneSource Specialty Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 761.3
- PEG Ratio
- 6.7
- Market Cap Cr
- 15,304
- P/B Ratio
- 2.6
- Average True Range
- 78.15
- EPS
- 2.67
- Dividend Yield
- 0
- MACD Signal
- -44.69
- RSI
- 50.94
- MFI
- 64.6
OneSource Specialty Pharma Financials
OneSource Specialty Pharma Technicals
EMA & SMA
Current Price
₹1,335.20
+
25.7
(1.96%)
- Bearish Moving Average 7
- Bullish Moving Average 9
- 20 Day
- ₹1,306.71
- 50 Day
- ₹1,410.02
- 100 Day
- ₹1,534.03
- 200 Day
- ₹1,614.84
Resistance and Support
1312.17
- R3 1,451.63
- R2 1,397.47
- R1 1,366.33
- S1 1,281.03
- S2 1,226.87
- S3 1,195.73
OneSource Specialty Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-23 | Quarterly Results | |
| 2025-11-11 | Quarterly Results | |
| 2025-08-04 | Quarterly Results | |
| 2025-05-05 | Audited Results | |
| 2025-01-29 | Quarterly Results |
OneSource Specialty Pharma F&O
About OneSource Specialty Pharma
- NSE Symbol
- ONESOURCE
- BSE Symbol
- 544292
- Managing Director & CEO
- Mr. Neeraj Sharma
- ISIN
- INE013P01021
Similar Stocks to OneSource Specialty Pharma
OneSource Specialty Pharma FAQs
OneSource Specialty Pharma share price is ₹1,335 As on 05 March, 2026 | 02:37
The Market Cap of OneSource Specialty Pharma is ₹15304.2 Cr As on 05 March, 2026 | 02:37
The P/E ratio of OneSource Specialty Pharma is 761.3 As on 05 March, 2026 | 02:37
The PB ratio of OneSource Specialty Pharma is 2.6 As on 05 March, 2026 | 02:37
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.